- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FDA Approves Dexcom's Continuous Glucose Monitoring Mobile App
The Share system has been classified as a novel but low-to-moderate risk device, exempt from the requirement for premarket submissions.
The FDA has approved the first-ever system of mobile medical apps that allow real-time data to be shared between a continuous glucose monitor and mobile devices such as an Apple iPhone.
The Dexcom Share Direct Secondary Displays system is the first wireless device that allows caregivers or other designated "followers" to remotely monitor glucose levels of a person with diabetes.
"This innovative technology has been eagerly awaited by the diabetes community, especially caregivers of children with diabetes who want to monitor their glucose levels remotely," Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health, said in a statement.
Link to the complete article on Medscape: http://bit.ly/1CoSOkp
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
